Plasma levels of Eicosapentaenoic acid are associated with anti-TNF responsiveness in rheumatoid arthritis and inhibit the Etanercept-driven rise in Th17 cell differentiation in Vitro
Plasma levels of Eicosapentaenoic acid are associated with anti-TNF responsiveness in rheumatoid arthritis and inhibit the Etanercept-driven rise in Th17 cell differentiation in Vitro
Objective. To determine whether levels of plasma n-3 polyunsaturated fatty acids are associated with response to antitumor necrosis factor (anti-TNF) agents in rheumatoid arthritis (RA), and whether this putative effect may have its basis in altering anti-TNF–driven Th17 cell differentiation.
Methods. Plasma was collected at baseline and after 3 months of anti-TNF treatment in 22 patients with established RA, and fatty acid composition of the phosphatidylcholine (PC) component was measured. CD4+CD25– T cells and monocytes were purified from the blood of healthy donors and cocultured in the presence of anti-CD3, with or without etanercept (ETN), eicosapentaenoic acid
(EPA), or the control fatty acid, linoleic acid (LA). Expression of interleukin 17 and interferon-γ was measured by intracellular staining and flow cytometry.
Results. Plasma PC EPA levels and the EPA/arachidonic acid ratio correlated inversely with change in the Disease Activity Score at 28 joints (DAS28) at 3 months (–0.51, p = 0.007 and –0.48, p = 0.01, respectively), indicating that higher plasma EPA was associated with a greater reduction in DAS28.
Plasma PC EPA was positively associated with European League Against Rheumatism response (p = 0.02). An increase in Th17 cells post-therapy has been associated with nonresponse to anti-TNF. ETN increased Th17 frequencies in vitro. Physiological concentrations of EPA, but not LA, prevented this.Conclusion. EPA status was associated with clinical improvements to anti-TNF therapy in vivo and
prevented the effect of ETN on Th17 cells in vitro. EPA supplementation might be a simple way to
improve anti-TNF outcomes in patients with RA by suppressing Th17 frequencies.
748 - 756
Jeffery, Louisa
f3c2d4cd-e958-4952-bd54-764a4efe8449
Fisk, Helena L.
2483d346-75dd-41b3-a481-10f8bb39cd9f
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Filer, Andrew
e4e9a33a-b98c-440d-b01a-8e9f4ec1f08c
Raza, Karim
c09be904-0dd6-4e7e-82b1-5f2f5be28ffc
Buckley, Christopher D.
a8c8f1a2-cee2-4010-b853-132509c8c113
McInnes, Iain
20f9fbe5-c0c7-4010-ba55-168ba553d07b
Taylor, Peter C.
2929ecfc-8a73-468b-947f-07a6b6d72659
Fisher, Benjamin A.
cfc4e3b8-d18c-42c1-9195-209f33e6201e
1 June 2017
Jeffery, Louisa
f3c2d4cd-e958-4952-bd54-764a4efe8449
Fisk, Helena L.
2483d346-75dd-41b3-a481-10f8bb39cd9f
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Filer, Andrew
e4e9a33a-b98c-440d-b01a-8e9f4ec1f08c
Raza, Karim
c09be904-0dd6-4e7e-82b1-5f2f5be28ffc
Buckley, Christopher D.
a8c8f1a2-cee2-4010-b853-132509c8c113
McInnes, Iain
20f9fbe5-c0c7-4010-ba55-168ba553d07b
Taylor, Peter C.
2929ecfc-8a73-468b-947f-07a6b6d72659
Fisher, Benjamin A.
cfc4e3b8-d18c-42c1-9195-209f33e6201e
Jeffery, Louisa, Fisk, Helena L., Calder, Philip C., Filer, Andrew, Raza, Karim, Buckley, Christopher D., McInnes, Iain, Taylor, Peter C. and Fisher, Benjamin A.
(2017)
Plasma levels of Eicosapentaenoic acid are associated with anti-TNF responsiveness in rheumatoid arthritis and inhibit the Etanercept-driven rise in Th17 cell differentiation in Vitro.
The Journal of Rheumatology, 44 (6), .
(doi:10.3899/jrheum.161068).
Abstract
Objective. To determine whether levels of plasma n-3 polyunsaturated fatty acids are associated with response to antitumor necrosis factor (anti-TNF) agents in rheumatoid arthritis (RA), and whether this putative effect may have its basis in altering anti-TNF–driven Th17 cell differentiation.
Methods. Plasma was collected at baseline and after 3 months of anti-TNF treatment in 22 patients with established RA, and fatty acid composition of the phosphatidylcholine (PC) component was measured. CD4+CD25– T cells and monocytes were purified from the blood of healthy donors and cocultured in the presence of anti-CD3, with or without etanercept (ETN), eicosapentaenoic acid
(EPA), or the control fatty acid, linoleic acid (LA). Expression of interleukin 17 and interferon-γ was measured by intracellular staining and flow cytometry.
Results. Plasma PC EPA levels and the EPA/arachidonic acid ratio correlated inversely with change in the Disease Activity Score at 28 joints (DAS28) at 3 months (–0.51, p = 0.007 and –0.48, p = 0.01, respectively), indicating that higher plasma EPA was associated with a greater reduction in DAS28.
Plasma PC EPA was positively associated with European League Against Rheumatism response (p = 0.02). An increase in Th17 cells post-therapy has been associated with nonresponse to anti-TNF. ETN increased Th17 frequencies in vitro. Physiological concentrations of EPA, but not LA, prevented this.Conclusion. EPA status was associated with clinical improvements to anti-TNF therapy in vivo and
prevented the effect of ETN on Th17 cells in vitro. EPA supplementation might be a simple way to
improve anti-TNF outcomes in patients with RA by suppressing Th17 frequencies.
Text
__soton.ac.uk_ude_PersonalFiles_Users_lce_mydocuments_Eprints - Professor Calder_Accepted publications for eprints_The Journal of Rheumatology_DATA study PUFA_Final_PURE.pdf
- Accepted Manuscript
More information
Accepted/In Press date: 21 December 2016
e-pub ahead of print date: 1 June 2017
Published date: 1 June 2017
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 403941
URI: http://eprints.soton.ac.uk/id/eprint/403941
ISSN: 0315-162X
PURE UUID: c80edb44-f6ed-4fed-8b59-8490cf7ce6fb
Catalogue record
Date deposited: 16 Dec 2016 12:04
Last modified: 16 Mar 2024 04:13
Export record
Altmetrics
Contributors
Author:
Louisa Jeffery
Author:
Helena L. Fisk
Author:
Andrew Filer
Author:
Karim Raza
Author:
Christopher D. Buckley
Author:
Iain McInnes
Author:
Peter C. Taylor
Author:
Benjamin A. Fisher
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics